NCT04685603 - Dendritic Cell Vaccine to Prevent COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2022

Conditions

COVID-19

Interventions

BIOLOGICAL

AV-COVID-19

Autologous dendritic cells previously loaded ex vivo with SARS-CoV-2 spike protein

Trial Locations (1)

RECRUITING

Rumah Sakit Umum Pusat Dr. Kariadi, Semarang

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Aivita Biomedical, Inc.

INDUSTRY

collaborator

PT AIVITA Biomedika Indonesia

UNKNOWN

collaborator

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

OTHER

collaborator

RSUP Dr. Kariadi Semarang, indonesia

UNKNOWN

collaborator

Faculty of Medicine University of Diponegoro, Indonesia

UNKNOWN

lead

Indonesia-MoH

OTHER_GOV